A Phase 2 Study of Cusatuzumab Plus Azacitidine in Patients with Newly Diagnosed Acute Myeloid Leukemia who are not Candidates for Intensive Chemotherapy.
- Wei, Andrew (Primary Chief Investigator (PCI))
- Kennedy, Nola (Project Manager)
Project: Research